Daily Care News for September 22, 2021
advertisement
- The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes
- Delays in Referral for Type 1 Diabetes in Children Common
- Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials
- Open-source automated insulin delivery systems for the management of type 1 diabetes during pregnancy
- Management of type 1 diabetes mellitus using open-source automated insulin delivery during pregnancy: a case series
- Comparable glucose control with fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system during exercise
- Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control – one-center retrospective assessment
- Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM
- Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus
- The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study (Full text HTML, PDF)
- Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes (Full text HTML, PDF)
- Nocturnal hypoglycemia in type 1 and type 2 diabetes: an update on prevalence, prevention, pathophysiology and patient awareness
- Novel continuous glucose monitoring metrics and LGA risk; an exploratory retrospective cohort study in pregnancies with type 1 diabetes
- CGM sensor glucose levels and insulin pump infusion set wear-time during treatment with fast-acting insulin aspart: a post hoc analysis of onset 5
- Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine
- Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes during One Year of the COVID-19 Pandemic
- Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics
- Use of connected pen as a diagnostic tool to evaluate missed bolus dosing behavior in people with type 1 and type 2 diabetes
- Device profile of the Eversense continuous glucose monitoring system for glycaemic control in type-1 diabetes: overview of its safety and efficacy
- Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users
- Real-world, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes using the MiniMed 670G Hybrid Closed Loop System
